Crosstalk of organelles in Parkinson’s disease – MiT family transcription factors as central players in signaling pathways connecting mitochondria and lysosomes

Abstract

Living organisms constantly need to adapt to their surrounding environment and have evolved sophisticated mechanisms to deal with stress. Mitochondria and lysosomes are central organelles in the response to energy and nutrient availability within a cell and act through interconnected mechanisms. However, when such processes become overwhelmed, it can lead to pathologies. Parkinson’s disease (PD) is a common neurodegenerative disorder (NDD) characterized by proteinaceous intracellular inclusions and progressive loss of dopaminergic neurons, which causes motor and non-motor symptoms. Genetic and environmental factors may contribute to the disease etiology. Mitochondrial dysfunction has long been recognized as a hallmark of PD pathogenesis, and several aspects of mitochondrial biology are impaired in PD patients and models. In addition, defects of the autophagy-lysosomal pathway have extensively been observed in cell and animal models as well as PD patients’ brains, where constitutive autophagy is indispensable for adaptation to stress and energy deficiency. Genetic and molecular studies have shown that the functions of mitochondria and lysosomal compartments are tightly linked and influence each other. Connections between these organelles are constituted among others by mitophagy, organellar dynamics and cellular signaling cascades, such as calcium (Ca2+) and mTOR (mammalian target of rapamycin) signaling and the activation of transcription factors. Members of the Microphthalmia-associated transcription factor family (MiT), including MITF, TFE3 and TFEB, play a central role in regulating cellular homeostasis in response to metabolic pressure and are considered master regulators of lysosomal biogenesis. As such, they are part of the interconnection between mitochondria and lysosome functions and therefore represent attractive targets for therapeutic approaches against NDD, including PD. The activation of MiT transcription factors through genetic and pharmacological approaches have shown encouraging results at ameliorating PD-related phenotypes in in vitro and in vivo models. In this review, we summarize the relationship between mitochondrial and autophagy-lysosomal functions in the context of PD etiology and focus on the role of the MiT pathway and its potential as pharmacological target against PD.

Transcriptome analysis reveals a new insights toward molecular mechanisms of Methylmalonic acidemia in hepatocytes

“…Surprisingly, our ndings in Fig. 2B demonstrated signi cant changes in the mTOR pathway upon exposure to excessive MMA, potentially contributing to unraveling the molecular mechanisms underlying methylmalonic acidemia, particularly in relation to the mTOR pathway, Ca 2+ , and mitophagy [41] . However, it's important to note that our study's limitation lies in focusing solely on transcriptomic analysis and the validation of the mechanism behind MMA-induced liver injury, lacking a deeper exploration of the regulatory interplay among mitophagy, ER-phagy, and Ca 2+ homeostasis.…”

Proteomics and metabolomics analysis of nasal lavage fluid in chronic rhinosinusitis with nasal polyps

“…Interestingly, we found that most of the DEPs enriched in the “Parkinson's disease” pathway were involved in “mitochondrial dysfunction.” We reviewed the patients' history and found that none of the patients with CRSwNP had Parkinson disease. Mitochondrial dysfunction is thought to play an important role in the pathogenesis of Parkinson disease 5 . Therefore, the proteins related to mitochondrial dysfunction are enriched in “Parkinson's disease” signaling pathways.…”

“…Mitochondrial dysfunction is thought to play an important role in the pathogenesis of Parkinson disease. 5 Therefore, the proteins related to mitochondrial dysfunction are enriched in "Parkinson's disease" signaling pathways. We selected 19 proteins for PRM validation, and found that the levels of 17 proteins were consistent with the results from proteomic data, which confirmed the reliability of our omics results (Figure S4).…”

Chiisanoside Mediates the Parkin/ZNF746/PGC-1α Axis by Downregulating MiR-181a to Improve Mitochondrial Biogenesis in 6-OHDA-Caused Neurotoxicity Models In Vitro and In Vivo: Suggestions for Prevention of Parkinson’s Disease

“…PD is associated with the dysregulation of the mitochondrial quality control system within DA neurons in the substantia nigra. Homeostasis of healthy mitochondria is achieved by fine regulation of molecules involved in mitochondrial biogenesis, mitophagy, and mitochondrial dynamics [ 44 ]. This study shows that 6-OHDA-induced damage and apoptosis of SH-SY5Y cells can be improved by enhancing mitochondrial biogenesis via CSS treatment.…”